RAPH — Raphael Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- $4.35m
- $4.60m
Annual cashflow statement for Raphael Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.761 | -1.63 | -3.36 | -1.34 | -1.52 |
| Depreciation | |||||
| Non-Cash Items | 0.105 | — | 2.29 | 0.2 | 0.39 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.174 | 0.206 | 0.309 | -0.059 | 0.597 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.831 | -1.42 | -0.759 | -1.2 | -0.532 |
| Capital Expenditures | -0.009 | — | -0.002 | — | — |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | -0.009 | — | -0.002 | — | — |
| Financing Cash Flow Items | — | 0.013 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.82 | 1.48 | 0.896 | 1.15 | 0.321 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.019 | 0.058 | 0.135 | -0.058 | -0.211 |